Cancer risk in a population-based cohort of patients hospitalized for psoriasis in Sweden

Journal of Investigative Dermatology

Volumn 117, Issue 6, 2001, Pages 1531-1537

  Boffetta, Paolo ^a,b,c   Gridley, Gloria ^b   Lindelöf, Bernt ^d  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b NATIONAL CANCER INSTITUTE   (United States)

^c KAROLINSKA INSTITUTE   (Sweden)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Alcohol drinking; Epidemiology; Malignant melanoma; Psoriasis; Skin neoplasms

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER; BREAST; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER RISK; CANCER STATISTICS; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC ERROR; DRINKING BEHAVIOR; FEMALE; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; LIVER; LUNG; MAJOR CLINICAL STUDY; MALE; MELANOMA; MOUTH CAVITY; PANCREAS; PENIS; PHARYNX; PRIORITY JOURNAL; PSORIASIS; SMOKING; SQUAMOUS CELL CARCINOMA; SWEDEN; VULVA;

EID: 0035678652     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0022-202x.2001.01520.x     Document Type: Article

References (46)

1. Cancer incidence in patients with psoriasis
2. Risk of cancer with cyclosporine in psoriasis
3. Cutaneous malignant melanoma
4. PUVA and skin cancer: A historical cohort study on 492 patients
5. Cutaneous T-cell lymphoma presenting as benign dermatoses
6. No association between malignant melanoma and acne or psoriasis: Results from the Western Canada Melanoma Study
7. Long-term follow-up of skin cancer in the PUVA-48 Cooperative Study
8. Malignant tumours and psoriasis: A follow-up study
9. Cutaneous melanomas in patients treated with psoralens plus ultraviolet A. A case report and the experience of the PUVA Follow-up Study
10. Cancer incidence among Finnish patients with psoriasis treated with trioxsalen bath PUVA
11. Psoriasis, its treatment, and cancer in a cohort of Finnish patients
12. Skin tumors in the European PUVA Study: Eight-year follow-up of 1,643 patients treated with PUVA for psoriasis
13. Hydroxyurea
14. X-radiation and γ-radiation
15. Psoriasis familial predisposition and environmental factors
16. Diseases associated with psoriasis in a general population of 159,200 middle-aged, urban, native Swedes
17. Grenz ray therapy in dermatology: An experimental, clinical and epidemiological study
18. Risk of melanoma with psoralen/ultraviolet A therapy for psoriasis: Do the known risks now outweigh the benefits?
19. The prevalence of malignant tumors in patients with psoriasis
20. PUVA and cancer: A large-scale epidemiological study
21. PUVA and cancer risk: The Swedish follow-up study
22. Completeness of the Swedish Cancer Register: Non-notified cancer cases recorded on death certificates in 1978
23. Cutaneous neoplasia following PUVA therapy for psoriasis
24. Alcohol consumption and psoriasis
25. Family history, smoking habits, alcohol consumption and risk of psoriasis
26. Frequency of malignant neoplasms in 248 long-term methotrexate-treated psoriatics: A preliminary study
27. Malignant tumors in patients with psoriasis
28. Breast and lung cancers in two cyclosporin-A-treated psoriatic women
29. Alcohol intake: A risk factor for psoriasis in young and middle aged men?
30. Incidence of cancer among patients with systemic sclerosis
31. Risk of squamous cell carcinoma and methoxsalen (psoralen) and UV-A radiation (PUVA)
32. Methotrexate used for psoriasis and the risk of noncutaneous or cutaneous malignancy
33. Cutaneous squamous-cell carcinoma in patients treated with PUVA
34. Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA)
35. Noncutaneous malignant tumors in the PUVA Follow-up Study: 1975-96
36. Oral psoralen and ultraviolet-A light (PUVA) treatment of psoriasis and persistent risk of nonmelanoma skin cancer
37. Nonmelanoma skin tumors in long-term photochemotherapy treatment of psoriasis
38. Reliability of record linkage in the Swedish Cancer-Environment Register